Chemoinformaics analysis of 2-(3-Methylphenyl)propan-2-ol
| Molecular Weight | 150.221 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 11 |
| Exact Molecular Weight | 150.104 | nRing | 1 |
| Solubility: LogS | -6.093 | nHRing | 0 |
| Solubility: LogP | 5.564 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 26.8371 |
| nHD | 1 | BPOL | 14.0449 |
| QED | 0.576 |
| Synth | 3.702 |
| Natural Product Likeliness | 2.399 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.007 |
| Pgp-sub | 0 |
| HIA | 0.003 |
| CACO-2 | -4.533 |
| MDCK | 0.00000973 |
| BBB | 0.731 |
| PPB | 0.980058 |
| VDSS | 2.313 |
| FU | 0.0218297 |
| CYP1A2-inh | 0.195 |
| CYP1A2-sub | 0.778 |
| CYP2c19-inh | 0.256 |
| CYP2c19-sub | 0.952 |
| CYP2c9-inh | 0.288 |
| CYP2c9-sub | 0.587 |
| CYP2d6-inh | 0.027 |
| CYP2d6-sub | 0.386 |
| CYP3a4-inh | 0.388 |
| CYP3a4-sub | 0.556 |
| CL | 13.119 |
| T12 | 0.086 |
| hERG | 0.033 |
| Ames | 0.019 |
| ROA | 0.029 |
| SkinSen | 0.483 |
| Carcinogencity | 0.039 |
| EI | 0.948 |
| Respiratory | 0.293 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.883459 |